SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-11-269906
Filing Date
2011-10-13
Accepted
2011-10-13 07:05:40
Documents
8
Period of Report
2011-10-13

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d241174d6k.htm 6-K 13690
2 UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS d241174dex1.htm EX-1 421025
3 MANAGEMENT'S DISCUSSION AND ANALYSIS d241174dex2.htm EX-2 66144
4 PRESS RELEASE DATED OCTOBER 13, 2011 d241174dex3.htm EX-3 26800
5 CANADIAN FORM 52-109F2 CERTIFICATION - CEO d241174dex4.htm EX-4 10879
6 CANADIAN FORM 52-109F2 CERTIFICATION - CFO d241174dex5.htm EX-5 10842
7 GRAPHIC g241174g53d04.jpg GRAPHIC 10084
8 GRAPHIC g241174g92f10.jpg GRAPHIC 21879
  Complete submission text file 0001193125-11-269906.txt   594700
Mailing Address 2310 ALFRED-NOBEL BLVD. MONTREAL A8 H4S 2B4
Business Address 2310 ALFRED-NOBEL BLVD. MONTREAL A8 H4S 2B4 514-336-7800
Theratechnologies Inc. (Filer) CIK: 0001512717 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1130
Type: 6-K | Act: 34 | File No.: 001-35203 | Film No.: 111138575
SIC: 2834 Pharmaceutical Preparations